BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND GATA2, NFE1B, 2624, ENSG00000179348, MGC2306, P23769 AND Diagnosis
50 results:

  • 1. [Gene Profile and Clinical Significance of Concomitant Mutations in CN-AML Patients with
    Zhu J; Kang YF; Gao Y; Wang HW; Hao ZH; Wang HW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):335-341. PubMed ID: 38660833
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Suspicion of constitutional abnormality at diagnosis of childhood leukemia: Update of the leukemia committee of the French Society of Childhood Cancers].
    Strullu M; Cousin E; de Montgolfier S; Fenwarth L; Gachard N; Arnoux I; Duployez N; Girard S; Guilmatre A; Lafage M; Loosveld M; Petit A; Perrin L; Vial Y; Saultier P
    Bull Cancer; 2024 Mar; 111(3):291-309. PubMed ID: 38267311
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cytogenetics in the management of bone marrow failure syndromes: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
    Cuccuini W; Collonge-Rame MA; Auger N; Douet-Guilbert N; Coster L; Lafage-Pochitaloff M
    Curr Res Transl Med; 2023; 71(4):103423. PubMed ID: 38016422
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. How I diagnose myeloid neoplasms with germline predisposition.
    Patel N; Calvo KR
    Am J Clin Pathol; 2023 Oct; 160(4):352-364. PubMed ID: 37458302
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Factors predicting survival following alloSCT in patients with therapy-related AML and MDS: a multicenter study.
    Baranwal A; Chhetri R; Yeung D; Clark M; Shah S; Litzow MR; Hogan WJ; Mangaonkar A; Alkhateeb HB; Singhal D; Cibich A; Bardy P; Kok CH; Hiwase DK; Shah MV
    Bone Marrow Transplant; 2023 Jul; 58(7):769-776. PubMed ID: 37012415
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Validation of the prognostic significance of the 2022 European leukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia.
    Lo MY; Tsai XC; Lin CC; Tien FM; Kuo YY; Lee WH; Peng YL; Liu MC; Tseng MH; Hsu CA; Chen JC; Lin LI; Sun HI; Chuang YK; Ko BS; Tang JL; Yao M; Chou WC; Hou HA; Tien HF
    Am J Hematol; 2023 May; 98(5):760-769. PubMed ID: 36861732
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. European standard clinical practice - Key issues for the medical care of individuals with familial leukemia.
    Förster A; Davenport C; Duployez N; Erlacher M; Ferster A; Fitzgibbon J; Göhring G; Hasle H; Jongmans MC; Kolenova A; Kronnie G; Lammens T; Mecucci C; Mlynarski W; Niemeyer CM; Sole F; Szczepanski T; Waanders E; Biondi A; Wlodarski M; Schlegelberger B; Ripperger T
    Eur J Med Genet; 2023 Apr; 66(4):104727. PubMed ID: 36775010
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia.
    Rudelius M; Weinberg OK; Niemeyer CM; Shimamura A; Calvo KR
    Virchows Arch; 2023 Jan; 482(1):113-130. PubMed ID: 36445482
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [gata2 gene mutations: 3 cases].
    Perrard N; Pokeerbux MR; Quesnel B; Duployez N; Fenwarth L; Preudhomme C; Lefèvre G; Baillet C; Launay D; Terriou L
    Rev Med Interne; 2022 Nov; 43(11):677-682. PubMed ID: 36041908
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. gata2 deficiency syndrome: A decade of discovery.
    Homan CC; Venugopal P; Arts P; Shahrin NH; Feurstein S; Rawlings L; Lawrence DM; Andrews J; King-Smith SL; Harvey NL; Brown AL; Scott HS; Hahn CN
    Hum Mutat; 2021 Nov; 42(11):1399-1421. PubMed ID: 34387894
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome.
    Taube F; Georgi JA; Kramer M; Stasik S; Middeke JM; Röllig C; Krug U; Krämer A; Scholl S; Hochhaus A; Brümmendorf TH; Naumann R; Petzold A; Mulet-Lazaro R; Valk PJM; Steffen B; Einsele H; Schaich M; Burchert A; Neubauer A; Schäfer-Eckart K; Schliemann C; Krause SW; Hänel M; Noppeney R; Kaiser U; Baldus CD; Kaufmann M; Herold S; Stölzel F; Sockel K; von Bonin M; Müller-Tidow C; Platzbecker U; Berdel WE; Serve H; Ehninger G; Bornhäuser M; Schetelig J; Thiede C;
    Blood; 2022 Jan; 139(1):87-103. PubMed ID: 34320176
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Laboratory evaluation and prognostication among adults and children with CEBPA-mutant acute myeloid leukemia.
    Mendoza H; Podoltsev NA; Siddon AJ
    Int J Lab Hematol; 2021 Jul; 43 Suppl 1():86-95. PubMed ID: 34288448
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Therapeutic options for CTLA-4 insufficiency.
    Egg D; Rump IC; Mitsuiki N; Rojas-Restrepo J; Maccari ME; Schwab C; Gabrysch A; Warnatz K; Goldacker S; Patiño V; Wolff D; Okada S; Hayakawa S; Shikama Y; Kanda K; Imai K; Sotomatsu M; Kuwashima M; Kamiya T; Morio T; Matsumoto K; Mori T; Yoshimoto Y; Dybedal I; Kanariou M; Kucuk ZY; Chapdelaine H; Petruzelkova L; Lorenz HM; Sullivan KE; Heimall J; Moutschen M; Litzman J; Recher M; Albert MH; Hauck F; Seneviratne S; Pachlopnik Schmid J; Kolios A; Unglik G; Klemann C; Snapper S; Giulino-Roth L; Svaton M; Platt CD; Hambleton S; Neth O; Gosse G; Reinsch S; Holzinger D; Kim YJ; Bakhtiar S; Atschekzei F; Schmidt R; Sogkas G; Chandrakasan S; Rae W; Derfalvi B; Marquart HV; Ozen A; Kiykim A; Karakoc-Aydiner E; Králíčková P; de Bree G; Kiritsi D; Seidel MG; Kobbe R; Dantzer J; Alsina L; Armangue T; Lougaris V; Agyeman P; Nyström S; Buchbinder D; Arkwright PD; Grimbacher B
    J Allergy Clin Immunol; 2022 Feb; 149(2):736-746. PubMed ID: 34111452
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Pulmonary Manifestations of gata2 Deficiency.
    Marciano BE; Olivier KN; Folio LR; Zerbe CS; Hsu AP; Freeman AF; Filie AC; Spinner MA; Sanchez LA; Lovell JP; Parta M; Cuellar-Rodriguez JM; Hickstein DD; Holland SM
    Chest; 2021 Oct; 160(4):1350-1359. PubMed ID: 34089740
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. What Is Abnormal in Normal Karyotype Acute Myeloid leukemia in Children? Analysis of the Mutational Landscape and Prognosis of the TARGET-AML Cohort.
    Herlin MK; Yones SA; Kjeldsen E; Holmfeldt L; Hasle H
    Genes (Basel); 2021 May; 12(6):. PubMed ID: 34064268
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Gene mutations in acute promyelocytic leukemia early death in patients treated with arsenic trioxide alone.
    Chen X; Fan S; Zhao Y; Zhou J
    Clin Transl Oncol; 2021 Oct; 23(10):2171-2180. PubMed ID: 33942222
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. diagnosis of gata2 Deficiency in a Young Woman with Hemophagocytic Lymphohistiocytosis Triggered by Acute Systemic Cytomegalovirus Infection.
    Burak N; Jan N; Kessler J; Oei E; Patel P; Feldman S
    Am J Case Rep; 2021 Mar; 22():e927087. PubMed ID: 33684095
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. diagnosis of rare subtypes of acute myeloid leukaemia and related neoplasms.
    George TI; Bajel A
    Pathology; 2021 Apr; 53(3):312-327. PubMed ID: 33676766
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. BCR-ABL1 positive AML or CML in blast crisis? A pediatric case report with inv(3) and t(9;22) in the initial clone.
    Behrens YL; Schienke A; Davenport C; Lentes J; Tauscher M; Steinemann D; Rasche M; Knirsch S; Joachim S; Reinhardt D; Schlegelberger B; Göhring G
    Cancer Genet; 2021 Jun; 254-255():70-74. PubMed ID: 33647814
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Effect of Signal Transduction Pathway Gene Mutations on the One- course Induced Remission Rate and Analysis of Clinical Characteristics in Patients with CBF-AML].
    Fan LF; Xu J; Chen XH; Tian TT; Xie J; Hu JJ; Guo ZP; Tan YH; Xu ZF; Ren FG; Zhang YF; Luo M; Ren WX; Wang HW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):781-788. PubMed ID: 32552936
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.